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ABSTRACT 
Natural Killer Activity in Gardner's Syndrome 
by 
Ann M. Stembridge, Master of Science 
Utah State University, 1983 
Major Professor: John R. Simmons 
Department: Biology 
Gardner's syndrome is an autosomal dominant disease presenting 
multiple colonic polyps with a predisposition for malignant change. In 
addit ion to colonic polyp formation by early adolescence, extracolonic 
lesions appear often prior to polyp formation. One theoretical 
mechanism for the origin of polyps and malignancies in Gardner's 
syndrome is a genetic defect in the natural killer cell activity of 
patients with this disease. Natural killer cells are a 
of lymphocytes that spontaneously lyse tumor cells 
subpopulation 
and virally 
transformed cells. A study was undertaken to determine the natural 
killer activity of patients with Gardner's syndrome . 
vi 
A technique termed chromium release was used to determine natural 
killer cell reactivity . This assay involves incubating patient's 
lymphocytes (effector cells) with tumor cells from a myelogenous 
leukemia cell line (target cells) which has been previously labeled 
with the radioactive isotope chromium-51. The level of isotope in the 
supernatant is believed to correlate with the natural killer activity 
of the subject. 
The results of this study indicate normal natural killer cell 
activity in patients with Gardner's syndrome. A trend toward lower 
natural killer cell activity was found at higher effector to target 
ratios in the patients. An incidental finding of higher natural killer 
activity in males (patients and healthy subj ects) than in females was 
made. Higher natural killer cell activity of male lymphocytes against 
the cell line K562 has not been previously reported. In conclusion, 
the natural killer cell activity of lymphocytes from patients with 
Gardner's syndrome against the cell line K562, is no different from 
that found by lymphocytes of healthy subjects. 
(46 Pages) 
INTRODUCTION 
Gardner's syndrome (GS) is an autosomal dominant disease 
presenting multiple colonic polyps with a predisposition for malignant 
change. GS was first reported by E.J. Gardner in Utah in the early 
1950's (Gardner, 1951). Victims of this disease usually develop 
colorectal polyps by early adolescence which continue to grow in size 
and number and if untreated, transform into adenocarcinoma. The 
syndrome has been clinically characterized by the colorectal polyps 
and one to several of the following extracolonic lesions: epidermoid 
cysts, osteomas, subcutaneous fibromas, desmoid tumors and dental 
abnormalities. 
One theoretical mechanism for the origin of the polyps and 
malignancies seen in GS, is a genetic defect in the natural killer 
(NK) cell activity of patients with this disease. Recently, a 
population of lymphocytes termed NK cells has been demonstrated to 
lyse, in vitro, tumor and virally transformed cells in man and 
experimental animals (Herberman and Holden, 1978). The NK cells 
require no prior priming to foreign antigens on the tumor or virally 
infected cells for lysis to occur. Since NK cells destroy tumor cells 
in vitro, it is believed that they have an important role in 
protecting against tumors. Hersey et al. (1979a) has found in some 
strains of mice that the inheritance of NK cell activity is autosomal 
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dominant as is segregation of susceptibility of GS in man. Warner and 
Dennert (1982) provide solid evidence for the role of NK cells as 
immune surveillants against tumors in vivo. They injected 
cyclophosphamide into two groups of mice making them NK cell 
deficient. One of the groups then received cloned NK cells three hours 
prior to injection with pulmonary tumor cells. The other group of mice 
did not receive NK cells. The mice were sacrificed three weeks later 
and those treated with cloned NK cells had 50-85% fewer pulmonary 
tumor colonies than the control group and had no metastes as compared 
to liver metastes found in the mice not receiving NK cells. The above 
findings led to an investigation of NK cell activity in GS. 
NK cell reactivity is determined by incubating lymphocytes from a 
subject (effector cells) with tumor cells (target cells) that have 
previously been labeled with an isotope of chromium-51. The NK cells 
lyse the target cells by damaging the target cell membrane. The label 
is released from the target cells and aliquots of culture medium are 
assayed for the amount of chromium released. The amount of chromium 
released correlates with the level of NK activity. 
Page 3 
REVIEW OF LITERATURE 
Gardner's Syndrome 
Colon cancer is the most frequent form of malignancy in the 
United States today. GS has been under investigation for the past 
thirty years. Much of the previous work on GS has involved defining 
t he disease, pedigree analysis, documenting case studies and 
investigating the possib il ity of chromosomal abnormalities (Gardner et 
al., 1982). 
In 1947, E.J. Gardner began studies on a family in which the gene 
for GS was segregating. This family has been designated as kindred 
l09, an abbreviated pedigree for this kindred is shown in Figure 1. 
he pedigree includes the individuals tested for NK cell activity. At 
the onset of the study, eight people had died from colon cancer with 
:he ninth soon to follow. All victims were in their mid-thirties at 
:he time of death. The pedigree clearly demonstrates the autosomal 
!ominant transmission of the disease. Six people in the pedigree were 
0 0und to have multiple polyps in their large intestine at the first 
>Greening. Of these six individuals, two have died, (one was the ninth 
1ictim and the other lived for 22 years after surgery and then died of 
tn unrelated cause) and the rest remain alive and in good health 
'Gardner, 1983). Gardner has found the onset of colonic polyps in 
ABBREVIATED KINDRED 109 
1 
'O(AO WITH CANC(R Or COLON BErORE THIS STUDY 
P 1 OEAO WITH CANCER OF' PANCREAS 8 28 
I • OEAO WITH INVASIVE FIBROMATOSIS 
0 • O(AO rROM NEGLECTED COLON POLYP CANCER 
M(TASTATIC TO THE BRAIN 
(E . J . Gardner, 1983) 
MALE FEMAL( 
0 0 
• • 
FREE FROM GARDNER 
SYNDROME 
GARDNER SYNOROM( 
Figure 1. Pedig~ee chart showing affected members of kindred 109. 
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kindred 109 to occur as early as 11 years of age and as late as 18 
years with an average of 14 years. Presently there is no test 
available at birth to determine, conclusively, if an infant has GS, as 
shown in Table 1. However, extracolonic lesions may be present at 
birth with osteomas being the most prevalent lesion. All kindred 109 
members have been found to have osteomas. If these ostemas are present 
at birth, they may be detected by a physical examination. There has 
been much success in Utah in extending the life of GS patients well 
beyond mid-thirties. This is done by regular proctoscopic examinations 
and surgical removal of polyps as the number found becomes too large 
to remove by cauterization at proctoscopic examinations (Gardner, 
1980). In Table 1., the treatment histories of the patients are 
presented . 
The mechanism of polyp formation in GS has been investigated by 
Deschner and Lipkin (1975) using kinetic studies with tritiated 
thymidine. Their results illustrate a continuous proliferation of the 
polyps as they pass the mid-level of the Crypts of Lieberkuhn upward 
to the mucosal surface (Figure 2.). These polyps may be peduncalated 
(hang on stocks of mucosa) or villous adenomas which are sessile and 
broad based at the mucosal surface. GS is a specific disease with 
polyp formation but is not synonymous with familial polyposis coli 
(FPC). In 1980, Gardner addressed the differences and similarities of 
GS and FPC. He asserts that GS patients have fewer but larger adenomas 
than FPC patients who are known to have a few hundred to to 5000 
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Table 1. Clinical Follow-up and Status of Patients 
and Internal Controls 
Age first Age first 
G.S . lesion colon Ag• of 
Pat tent recorded adenO'!Ia Status Pat lent 
* IV · 8 14 col oHomy 51 
* IV-10 13 colostcrny 45 
* IV- 20 10 14 subtotal colectc.ny 41 
" 
IV-21 2 18 subtotal colectO'Tiy 38 
IV-JO 2 14 died at 30 frcn mesenteric f1bro· JO 
matosts 
lV-31 18 18 died at 23 from mesenteric ffbro- 23 
matosh 
V-20 12 subtotal colectcmy 20 
* V-21 11 subtotal colectcxny 18 
* V-28 At birth 16 subtotal colectany zz 
V-29 control 20 
V-30 15 mul tfple adencxnas 18 
o V-31 Gardner syndrcrne 14 
V-32 control 12 
0 V-33 At bl rth Gar"dner syndrome 
*V-J4 At birth C.Hdner syndrane 
V-62 13 multiple adenomas 18 
*v-63 11 multiple adencm.as 15 
V-66 G<~rdner syndrome 6 
V-84 14 subtotal colectcmy 21 
Vl-13 At risk 
Vl -39 At risk 
Vl-39a At risk 
Average 4. 7 14 
*Gardner's syndrome patients tested for NK activity
1 83
) {E.J. Gardner, 9 
~ 
. ~ 
(M.F. Kagno~~. 1981) 
SmooLh muscle 
'8 LYJ.4PHOCYTCS1 
T LYMPHOCTT(S ( 
P\,.ASMA C(LLS \ l.l.MII~t. 
MACROPHH,(S ,' PROPRIJ. 
MAST CELLS I 
.. ( OSINOPHILS j 
lymphatic 
intestine. 
Figure 3. Schematic representation of ari intestinal 
villous and immune system factors present. 
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adenomas carpeting their large intestine. Polyps found in both groups 
are similar if not identical in terms of histology, pathology, and 
genetics but, the major difference between the two diseases is the 
lack of extracolonic lesions in FPC patients and the presence of one 
or more of these lesions in GS patients. In addition, St. Mark's 
Hospital in London has placed the average age of onset in FPC patients 
to be ten years later than that of GS patients. 
To date there has been no immunological research on GS except for 
one study done by Berlinger et al. in 1977. Mixed lymphocyte culture 
assays focusing on lymphocyte responsiveness and the modulatory role 
of adherent mononuclear cells were completed on a mother and daughter 
with GS. Results of these studies suggest decreased responses in these 
women as compared to those subjects without GS. The investigators 
theorize a deficit of recognitive immunity may be an unsuspected 
component of GS. 
Review of the Immune System 
The primary components of the immune system in man are the B 
cells and the T cells. B cells originate in the bone marrow and 
produce antibodies whereas T cells are derived from the thymus and can 
be delineated into at least three subpopulations: 
1. Cytotoxic T cells which lyse foreign cells . 
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2. Helper T cells which are necessary for antibody production 
and the development of cytotoxic T lymphocytes (CTL). 
3. Suppressor T cells which suppress expression of the immune 
system. 
T cells are also known to produce humoral factors called lymphokines 
which assist in the functioning of the immune system. Lymphokines 
should not be mistaken as antibodies. Two important lymphokines that 
cause proliferation of NK activity l evels in the peripheral blood of 
man are interferon and T cell growth factor also known as 
Interleuk i n-2. 
Macrophages are not considered to be part of the immune system 
but are thought to work in conjunction with BandT cells in the 
production of antibody and development of cell-mediated immunity. 
Macrophages destroy 90-98% of the foreign substance which enters the 
body and then deliver the remaining antigenic substance to the BandT 
cells . 
Cytotoxic T lymphocytes (CTL), K cells and NK cells are similar 
in function but their mechanisms of killing differ. CTL need to be 
exposed to an antigen for seven to fourteen days before they become 
cytotoxic. K cells and NK cells are not classified as either B or T 
cells but are considered more primitive cell forms. They both have 
receptors for IgG and need no prior sensitization for mediating 
cytotoxicity, however; K cells require antibody coated cells to 
mediate lysis and NK cells do not. Table 2. summarizes the cells of 
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the immune system. (Reviewed by Herberman and Ortaldo (1981)). 
Origin of NK Cells 
Major controversies over the origin of NK cells have been in 
existence since the discovery of these cells in the early 1970's. Are 
NK cells immature T cells or are they a separate lymphoid population? 
Also, are NK cells and K cel ls the same or divergent lymphoid lines? 
These questions have not been answered but many have speculated and 
conducted experiments in attempt to answer these questions. 
Timon en et al. ( 1981) have isola ted large granular lymphocytes (a 
subpopulation of lymphocytes) that are 50% larger than most other 
lymphocytes and have kidney-bean shaped nuclei and nuclear azurophilic 
granules. These granular lymphocytes express NK activity and 
antibody-dependent cellular cytotoxicity. These lymphocytes are found 
in highest concentration in the peripheral blood and lungs each (7% of 
the total), the spleen (4%), peritoneal exudates (3%), and lymph nodes 
(1%) but few if any are found in the thymus or bone marrow. Based on 
experiments with the T cell growth factor, Herberman (1982) proposes 
that large granular lymphocytes have diverged from "T stem cell 
lineage". NK cells retain NK morphology and activity for seven days, 
at which time, the cell surface markers shift to those found on mature 
T-cells. Timonen et al. suggest that T cell growth factor may "push" 
the large granular lymphocytes to further differentiation. 
Table 2. Revie~1 of the Immune System 
Morphology 
Siz:e 
Nucleus 
Adherence-plastic 
Cell ~urface 
markers for 
sheep RBC 
fhagocytosis 
Antigens 
(Hllr.lan) 
functional 
Cho.racleristlcs 
Spontaneous 
reaetlvt ty 
Response lime 
Nature of target 
Grolrth factors 
Possl ble mecha-
nism of cyto-
toxlci ty 
NK cells 
12-1~s 
Slightly indented 
No 
Yes on about .50~ 
(low affinity) 
No 
Most or all cells• 
HNK-1, OKH1, asialo-GH 1, 
OKT10 
~ubse~s• 9.6, ln 
Yes 
In vivo1 within 4 hrs. 
in vitro: within 1 hr. 
At lea~t several widely 
distributed antigenic 
speclflcitles 
TCCf 
Protease, PhosPholipase, 
cytotoxin 
Production of IfN, TCGf 
soluablc mediators 
T cells 
9-12 11\lcrons 
Round 
No· 
Yes (high affinity) 
No 
Most or all eells1 
9.6, OKT) 
aubsotSI OKT4, OKT8 
No 
Pri~ry response• 5-7 days 
memory response! 2-5 days 
llide array or specific 
antigens; important role 
of HHC restricted antigens 
TCGf 
Protcase, ·osmotic 
llide array of lymphoklnes . 
Hacrofha.ges 
12-16 11\lcrons 
Markedly indented 
Yes 
No 
Yes 
Most or all cells• 
OKH1, asialo-GH 1 
subsct1 la 
Yes 
In vtvo1 5-10 days 
in vitro• about 18 hrs. 
Specific~ty not clearly 
definedt selectivity for ' 
t umo~· ta:cgets 
Colony stimulating factor 
Reactive oxygen species, 
protease, lysozyme, phago-
cytosis, PGE, IfN 
LAF, PGE, IFN, Colony 
stimulating factor 
(R.B. Herber~il, 1982) 
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Perhaps not all populations of NK cells in mammals have diverged 
from the T stem cell 1 ineage. Hersey et al.(1979a) discovered in mice 
having a congenital lack of thymus (nude mice) and in mice neonatally 
thymectomized, that higher NK activity exists than is found in other 
strains of mice. Also when T cells are depleted from mice with 
anti-sera directed against T cells, NK cells demonstrate an increased 
activity. These experiments suggest that NK cells do not originate 
from the T cell lineage in some cases but instead arise from bone 
marrow. 
In recent years, there has been a proliferation of papers 
concerning NK cells and K cells and their similarities and 
differences. Gupta (1980) believes that three different subpopulations 
of lymphoid cells exist including, cells capable of mediating both NK 
and antibody-dependent cellular cytotoxicity, cells capable of 
mediating NK cell cytotoxicity alone, and cells capable of mediating 
antibody-dependent cellular cytotoxicity alone. Helms and Bull (1980) 
prefer a model of a single effector cell acting through two separate 
mechanisms. They found that the elimination of monocytes from an 
effector cell population resulted in an increase in the NK cell 
cytotoxicity and antibody-dependent cellular cytotoxicity. Enzyme 
treatments showed marked differences between NK and K cell activity 
which may suggest that two different receptor sites are involved. 
Pretreatment of effector cell populations with neuraminidase 
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diminished K cell activity and increased NK activity, whereas, 
pretreatment with trypsin reduced NK killing but had no effect on K 
cell killing. Hahn et al. (1978) agree with Helms and Bull on their 
proposed model and cite some additional evidence that one effector 
cell mediates both K and NK cell activity. They found when passing 
peripheral blood lymphocytes over nylon wool columns, that K cell 
killing increased and NK cell killing did not . If lymphocytes are 
stored at room temperature overnight in medium with fetal calf serum, 
antibody-dependent cellular cytotoxicity increases while NK activity 
remains unaltered. Lastly, a fluctuation in NK activity is found from 
month to month but no fluctuation occ urs inK cell activity. Hahn et 
al. theorize the fluctuation is present because of the heterogeneity 
of the NK cell population. 
Until recently, fragment crystalline receptors were found only on 
K cells, but now they can be demonstrated on both NK and K cells. In 
1980, Nelville sucessfully separated NK cells from K cells by buoyant 
density centrifugation. Together NK and K cells represent 2-3% of the 
lymphocyte population or 20-30% of the receptor bearing cells. The NK 
and K cells are activated to lyse target cells by different 
mechanisms, Nelville found that NK cells bind to P-815-Ab cells but do 
not lyse them, inversely, K cells bind to K562 cells but do not lyse 
them either. Therefore, binding is not sufficient to cause lysis. This 
researcher proposes that two different fragment crystalline receptor 
bearing lymphocyte populations exist, where in K cells, these fragment 
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crystalline receptor populations activate the K cells to become 
cytotoxic and lyse antibody coated cells, and the other receptor 
population signals cytotoxicity toNK cells for NK sensitive targets. 
Mechanisms of NK 
There is no general consensus among researchers on the mechanism 
of natural killing. Wright and Bonavida {1983b) have published a 
series of papers proposing that natural killer cytotoxic factors are 
involved in NK. They found that nude mice with high NK activity also 
possessed high levels of cytotoxi c factors, and, conversely, other 
mice with low NK levels had low cytotoxic factor levels. They define 
natural killer cytotoxic factors as non-adherent, Thy-1.2 negative 
factors , with asialo-GM markers on surface membranes. These factors 
are found to be active on target cells sensitive to NK lysis. Their 
model of cytolysis is based on sequential steps as follows: first the 
effector cell recognizes and binds to the target cell. The target cell 
then emits a signal to the effector cell which activates the lytic 
cycle. The effector cell releases cytotoxic factors which bind to the 
target cell and lysis occurs. 
Roder {1980) found that dinitrophenol and sodium azide inhibited 
NK cell lysis but did not block effector-target cell binding. He 
hypothesizes that energy is necessary to expose the enzyme's active 
site to the cell's exterior and suggests an esterase as the enzyme 
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responsible for this activity. Hiserodt et al. (1982) agree that 
effector-target cell binding may play a passive role with no 
temperature requirements and little energy or ·membrane movement 
necessary. They feel that interferon steps up the programming for 
lysis by changing the membrane of effector cells and allowing 
increased expression of the lytic elements. 
Pucetti et al. (1979) have followed work started by Djeu et al. 
(1979) regarding a functional relationship between NK and macrophage 
activity. They agree with Djeu et al. that macrophages are necessary 
for the production of interferon and an increase of NK activity when 
poly l:C is used. Pucetti et al. theorize that a common link between 
NK and macrophages may only occur upon release of interferon. When 
using a large dose of pyran copolymer, a reticulo-endothelial 
stimulating agent and interferon inducer, to activate macrophages, 
they found a decrease in NK activity. This observation agrees with 
that of others who find that macrophages are able to both activate and 
suppress NK activity. They are not ruling out a suppressor cell acting 
to lower NK activity, but prefer their theory that a cellular 
association exists between NK cells and macrophages. 
In addition to interferon, interleukin-2 is being investigated as 
a lymphokine of primary importance to the NK mechanism. Domzig et al. 
(1983) have examined in vitro, the effect of interleukin-2 in humans 
by utilizing a monoclonal antibody against interleukin-2. Depleting 
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anti-interleukin-2, did not effect the capacity of NK cells to 
rejuvenate, if the cells were treated for less than twenty hours . 
However, depleting for more than twenty hours, resulted in NK cells 
completely devoid of interleukin-2. Only with the addition of 
extraneous interleukin-2 did NK activity reappear. No interferon was 
detected in these samples of interleukin-2 or anti-interleukin-2 so 
that all subsequent findings could be attributed solely to 
interleukin-2. Kawase et al. (1983) found that interleukin-2 
preparation from human or mouse tissues is able to stimulate 
interferon production in mice spleen cells. As much interferon was 
produced in nude mice as in CBA mice suggesting mature T cells play no 
role in interferon production. When macrophages and NK like cells are 
exposed to interleukin-2, a cooperative effort exists between these 
cell types to produce interferon. Kawase et al. suggest a two stage 
approach to interferon production and subsequent NK boosting. In the 
first stage, one to several soluable mediators are generated from the 
macrophages that may act alone or in conjunction with interleukin-2 to 
produce interferon from these NK like cells which bear asialo-GM-1 and 
NK-1.2 markers. The second step involves boosting NK activity from the 
newly produced interferon. The mechanism of interferon and 
interleukin-2 on NK activity are unknown, but many agree that these 
lymphokines are important in maintaining a healthy, active NK cell 
population. 
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The researchers whose work was discussed above have tried to 
delineate the NK mechanism under normal circumstances, but what, if 
any, changes occur under adverse conditions such as cancer or other 
disease conditions? A profound defect of NK cell activity has been 
found in humans {Roder et al., 1980) and is termed Chediak-Higashi 
syndrome. This syndrome is caused by an autosomal recessive gene which 
is analogous to the recessive "beige" gene in mice. These individuals 
have normal humoral immunity and delayed type hypersensitivity, but 
suffer pyrogenic infections in childhood and have high risks of 
contracting lymphoproliferative disorders if adulthood is reached. 
Given high doses of purified interferon over a a twenty-four hour 
period, these patients are able to respond like controls. Targan and 
Oseas {1983) suggest a defect in their post-binding mechanism of lysis 
to cause the low levels and delay in NK activity. 
Tumors are theorized to secrete prostaglandins that may lower NK 
activity. Roder and Klein {1979 ) using an inhibitor of prostaglandin 
synthesis termed indomethacin, demonstrated a small but significant 
increase of the NK cytolytic response in mice. 
Steinhauer et al. {1982) have found a difference in NK activity 
in patients with advanced cancer. The number of large granular 
lymphocytes and effector-target binding cells was no different in 
advanced cancer patients than it was in other cancer patients and 
normal subjects. In a normal functioning system, the individual NK 
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cell is able to make a lethal hit, recycle and induce another lethal 
hit . In these advanced cancer victims, the defect results from the 
inability of the NK cell population to recycle despite normal numbers 
and binding capacities. 
NK Activity in the Gut Lymphoid Tissue 
Studies of NK activity or antibody-dependent cellular 
cytotoxicity in gut lymphoid tissue are pertinent when investigating 
GS and its localization of polyp formation in the colon. Clancy and 
Pucci (1978) have looked at antibody-dependent cellular cytotoxicity 
in healthy and inflamed human gut mucosa and conclude that no activity 
is present. Arnaud-Battandier et al. (1978) have extended the former 
study and have investigated NK and antibody-dependent cellular 
cytotoxicity in guinea pigs. The guinea pig gut lymphoid tissue was 
separated into the lamina propria and the intraepithelial tissue 
(Figure 2. and 3.). Lamina propria contains plasma cells for antibody 
production and the intraepithelial tissue contains 90% of the 
lymphocytes. The researchers assessed NK and antibody-dependent 
cellular cytotoxicity in the spleen cells, lamina propria, 
intraepithelial lymphocytes, Peyer's patches and mesenteric lymph 
nodes. The NK activity was at the highest level in the spleen cells 
following with a moderate level of activity in the intraepithelial 
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lymphocytes, a minimal 1 evel in the mesenteric lymph nodes and no 
activity in the Peyer's patches. Similar results were obtained with 
the antibody-dependent cellular cytotoxicity assay. Arnaud-Battandier 
et al. concl ude that the 1 ack of NK and antibody- dependent cellular 
cytotoxicity in mesenteric lymph nodes and Peyer's patches is due to a 
lack of fragment crystalline receptor positive cells in these tissues. 
Age, Sex and Environment 
Affecting NK Levels in Man 
Uks il a et al . (1983) studied NK activity in premature human 
newborns and aborted fetuses. They found a progressive development of 
NK cell function during the last third of intrauterine life. In a 
nineteen week old fetus, NK activity was evident in the liver and 
spleen but not in the thymus or bone marrow suggesting that NK cells 
do not evolve from B or T progenitor cells. Lymphocytes from cord 
blood at birth show levels of cytotoxicity that are higher than that 
of the peripheral blood lymphocytes from premature infants but lower 
than that of cells found in adults. Toder et al. (1983) initiated a 
study looking at NK activity in healthy pregnant women and pregnant 
women with edema-proteinurea-hypertension. This condition is a partial 
or total malfunction of either the fetal or the maternal immune 
system. A normal pregnancy does not specifically alter the NK level 
whereas in women with this condition, the NK level is doubled. Upon 
addition of interferon, the normal pregnant woman's NK level is more 
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than doubl ed but little or no enhancement is found in 
edema-proteinurea-hypertension gestosis women. Toder et al. propose 
that the pre-NK or undifferentiated NK cells in these women may 
undergo some activation by an unknown factor, other than interferon. 
Whether this activation is a manifestation of the disease or a 
secondary response is unknown. 
A study done by Hersey et al . (1979b) examined the NK level of 
pati ents with melanoma and their families. The findings suggest a 
lower NK activ i ty in melanoma patients and closely related relatives. 
In families free of melanoma, the influence of genetic and 
environmental factors on NK levels was not as apparent as in the 
melanoma families . 
In 1981, Nagel et al. published their findings on a longitudinal 
study done in Baltimore on 150 men and 50 women aged 20-95 years. 
Nagel concluded that NK activity against a myelogenous leukemia cell 
line K562, was independent of age, sex and whether or not the NK cell 
donor smoked. In patients forty to seventy-five years of age, a 
decrease in the level of cytotoxicity was evident but, this decrease 
was not significant. However, a higher NK activity was found for 
those 75 years of age and older. Nagel theorizes that the higher NK 
activity gives the subject a survival advantage. One could consider 
that individuals with lower NK activity, if it does indeed render 
immune surveillance, have previously died. No data were compiled in 
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this study for individuals under twenty years and no other studies 
have been done at this time. Penschow and Mackay (1980} have 
demonstrated an increase in NK activity in males and younger healthy 
controls when measuring NK activity with the Chang cell line. The K 
cell activity did not differ in their study according to sex or age. 
The different findings of Nagel and Penschow and Mackay are most 
likely due to the different cell lines used. 
Herberman (1982} has published his own ideas on possible future 
clinical applications of NK cells in disease conditions such as 
cancer. Peripheral blood of a cancer patient could be drawn and NK 
cells isolated from the other lymphocyte populations. These isolated 
NK cells could then be cultured in T cell growth factor until the 
cells increase by 10x106. These cloned cells may then be injected back 
into the cancer patient and theoretically, the increased NK cell 
population should eradicate the tumor. 
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MATERIALS AND METHODS 
The Natural killer activity is determined by utilizing the 
chromium release assay with 51cr. The procedure is given below and 
modified from Jondal (1976). 
Preparation of Lymphocytes 
1. Thirty to sixty ml of heparinized blood is drawn from each 
subject (.2ml of 1000 ~ / ml of preservative free heparin 
(Sigma St. Louis, Mo.)) . 
2. The blood is either used undiluted or mixed with an equal 
volume of phospate buffered saline (.OlM phosphate and .15M 
NaCl). If the plasma is to be retained, the blood is 
centrifuged at 2000 rpm for 15 minutes in an IEC centrifuge 
Next the diluted blood is layered over 3.5 ml of 
Ficoll-Hypaque gradient (specific gravity 1.077-1.080 g/ml)in 
a 15 ml centrifuge tube and centrifuged at 2000 rpm for 20 
minutes. 
3. The lymphocyte population, located at the interface on the 
gradient, is removed and subsequently washed at 1500 rpm for 
10 minutes in phosphate buffered saline. The cells are 
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decanted and then are resuspended in the saline and 
centrifuged at 1000 rpm for 5 minutes. The cells are then 
counted and suspended in RPMI-1640 (Gibco, Grand Island, 
N.Y.) that has been supplemented with IO,OOO units of aqueous 
penicillin and 10 mg. streptomycin/100 ml solution. If stored 
overnight, the medium is supplemented with 20t autologous 
plasma and the lymphocytes are held at a concentration of no 
more than 2x106/ml in solution. The lymphocytes are stored at 
room temperature. 
Target Cell Preparation 
1. The target cells are subcultured 24 hours before use to 
assure a healthy population. The target cells are from a 
human myelogenous leukemia line termed K562 and are 
maintained in RPMI-1640 with 10% fetal calf serum (Sterile 
Systems, Logan, Ut.) in 5% C02 and 37°C. The cells are passed 
twice weekly. 
2. On the morning of the assay, the subcultured K562 cells are 
centrifuged and 0.1 ml of autologous plasma and 0.1 ml of 
sodium chromate (Na251 cro4) are added at a concentration of 3 
miCi/ml and a specific activity of 300-400miCi/mg (New 
England Nuclear, Boston, Ma.). The target cells are then 
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incubated for one hour without shaking in a 5% co2 incubator 
at 37°C. 
3. After one hour, the target cells are resuspended in 15 ml 
RPMI with 10% autologous plasma and centrifuged at 1000 rpm 
for 3 minutes. The cells are then washed 3 more times using 
the same procedure and suspended at a final concentration of 
1x1o5;m1. 
Effector Cell Preparation 
1. While labeling the target cells, a Linbro 96 well 
round-bottomed microtiter plate is prepared by adding 0.1ml 
of .5% saponin detergent {maximum release) and 0.1ml of 20% 
autologous plasma in RPMI {control release) in triplicates to 
the wells. 
2. The lymphocytes are then pipetted into the microtiter plate 
at concentrations of 50 effectors to 1 target cell, 25:1, 
12:1, and 6:1. 
3. A multiple pipetter is used to add the targets to the wells. 
The plate is then incubated for 4 hours at 37°C and 5% co2. 
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4. After the incubation, O.lml of supernatant is pipetted from 
each well and counted for five minutes in a Beckman gamma · 
counter. The spontaneous release is calculated by dividing 
the control release by the maximum release. The spontaneous 
release averaged 26% for this assay. 
5. The calculation for% release is as follows: 
=experimental release- control release x 100 
max1mum release - control release 
Experimental release is obtained from incubating the lymphocytes 
with the target cells, the control release is from target cells 
incubated in medium alone and the and the maximum release from target 
cells incubated in a detergent. 
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RESULTS AND DISCUSSION 
Results 
Figure 4, shows the results ~f st~dyi~g seven p~ti~n~s wit~ GS 
and seven healthy subjects who were age and sex matched with the 
patients. An analysis of variance (Table 3.) indicates that no 
statistical difference exists between the NK activity of controls and 
GS patients at any of four effector to target ratios. However, at the 
higher effector to target ratios, a suggestion of difference is 
evident with the controls demonstrating a higher NK activity level. 
Another analysis of variance was computed for a difference in NK 
reactivity between males and females. The men had a higher NK activity 
at all four ratios (p< .1 F test, Table 4.). 
The mean age of the ten women sampled was 28.8 ± 16.2 years which 
included two girls aged 8 and 10 years. These younger women had higher 
NK activities than the older women. The men assayed (including 
patients and healthy subjects) had a mean age of 34.73 ± 14.35 years 
with a concentration of men over 40 years of age. A lower level of NK 
was found in the men over 40 years than in the younger men; there were 
too few women over 40 years in this study to make the same assesment. 
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NATURAL KILLER REACTIVITY 
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Figure 4. Natura l Killer reactivity in Gardner's syndrome vs . controls 
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Table 3. Analysis of Variance for Gardner's Syndrome vs. Controls 
Source dF Sum of Sguares MSE F test ~--
-6 4849.356 808.226 
Group 980.294 980.294 l. 102 Error A 6 5335.237 889.206 
Ratio 3 8049.268 2683.089 
G x R 3 334.313 111.438 2.236 Error B 36 1794.321 49.842 
Total 55 21342.791 388.051 
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NATURAL KILLER REACTIVITY AND SEX 
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Figure 5. Natural Killer reactivity in males vs. females 
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Table 4. Analysis of Natural Killer Activity in Males vs. Females 
A. Analysis at 50:1 between male and female 
Source dF Sum of Sguares MSE F test 
Treatment -1- 737.489 737.489 3. 15_ * 
Error 19 4454.749 234.461 
* Significant at .90 level 
8. Analysis at 25:1 between male and female 
Source dF Sum of Sguares MSE F test 
Treatment -1- 988.099 988.099 3.85 * 
Error 19 4884.819 257.096 
c. Analysis at 12:1 between ma l e and fema le 
Source dF Sum of Sguares MSE F test 
Treatment -1 479. 46 7 479.467 3.07 * 
Error 19 2968 .959 156.261 
D. Analysis at 6:1 between male and female 
Source dF Sum of Sguares MSE F test 
Treatment -1- 285.016 285.016 3.29 * 
Error 19 1645 .456 86.603 
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Attempts were made to use CCL-218 (ATCC, Rockville, Md.), a 
colorectal adenocarcinoma cell line as target cells for NK cell 
reactivity because there are no GS adenocarcinoma lines available at 
present. Labeling of these cells was attempted using the procedure 
described in "Methods" but the spontaneous release was always in an 
excess of 50%. In an effort to lower this release, the target cells 
were labeled, washed and then allowed to incubate in a Linbro 96 flat 
bottomed plate for several hours before effector cells were added as 
suggested by Brunner et al. (1976). This procedure did not remedy the 
problem of high spontaneous release, so study of this cell line was 
discontinued. 
Discussion 
Santol i et al. (1976) and Penschow and Mackay ( 1980) have 
reported that lymphocytes of men have a higher NK activity against the 
Chang cell line than do those of women. In the present study, a higher 
NK activity also was found in men against the K562 cell line which had 
never been reported before. Hersey et al. (1979b) reported familial 
inheritance of NK activity in melanoma patients and close relatives 
but no such inheritance was seen in the three GS families sampled. 
There was no success using CCL-218 to measure NK cell activity, 
however; there are reports that HCT-8, a colorectal line, labels well 
with 51 cr. In retrospect it may have been a better choice of cell line 
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to use. The best colorectal line to use, if it could be labeled with 
51
cr, would be tissue cultured from a GS adenocarcinoma. If such a 
line could be isolated and cultured, the GS adenocarcinoma would be 
disease specific and have the greatest promise for delineating a 
difference in NK activity between patients and controls. The K562 cell 
line used in the present study is a myelogenous leukemia ce11 line 
which is not disease specific but rather the most common line used to 
assay NK activity in humans. 
No significant decrease in NK activity was found in GS 
individuals when peripheral blood lymphocytes were used in the assay. 
However, a difference might exist if lymphoid tissue from the gut were 
sampled. Polyps are not adenocarcinoma but, simply adenomas with the 
potential to transform. It is possible that these polyps secrete some 
inhibitor, such as prostaglandins, as has been suggested by Droller et 
al .(1978) which inactivates the immune system. Also, these polyps may 
not have any tumor associated antigens (TAA) on their surfaces or any 
markers that the immune system could recognize as foreign. GS patients 
may be specifically tolerant to the TAA or other markers possibly 
present on the polyp cell surface. 
Testing peripheral blood lymphocytes for NK may not be a 
sensitive enough evaluation for the specialized polyp formation 
ongoing in the colon of GS patients especially when considering the 
possibility that NK cells may not be dispersed evenly through all gut 
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tissue. The polyps normally found in the gut of GS patients have a 
lamina propria base and are covered on the surface by intraepithelial 
lymphocytes. Could there be an inherent genetic defect in the 
intraepithelial lymphocytes which are unable to stop the progressive 
formation of these gut adenomas? For this to be ascertained, gut NK 
cells separated by techniques of Arnaud-Battandier et al.(l978) could 
be tested for activity. 
Other immune functions should be investigated in the future. They 
include mitogen stimulation with phytohemagglutinin, concanavalin A, 
lipopolysaccharide and pokeweed mitogen to discern i f T cell 
subpopulations and B cells are functioning normally in these patients. 
Possibly the helper Tor cytotoxic T cells are not functioning in the 
lamina propria and allowing formation of these polyps. Another 
important area of future investigation is to perform human leucocyte 
antigen (HLA) typing on all GS patients and see if there is a 
correlation of HLA with the disease. 
Conclusion 
The NK cell activity against myelogenous leukemia cell line K562 
was tested in patients with GS and no significant difference was found 
in these patients as compared to findings in healthy subjects. A 
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difference was noted in NK activity between male and female subjects 
tested. Males exhibited a higher NK cell activity against K562 cells 
(p< .10) than the females . NK cell activity should be considered for 
future study in patients with GS but , different and more specific cell 
lines should be tried in these investigations. 
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